4//SEC Filing
Vyas Dolatrai 4
Accession 0001209191-21-042434
CIK 0000831547other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:06 PM ET
Size
9.1 KB
Accession
0001209191-21-042434
Insider Transaction Report
Form 4
Vyas Dolatrai
Director
Transactions
- Award
Common Stock, $0.001 par value
2021-06-17+14,277→ 95,346 total - Sale
Common Stock, $0.001 par value
2021-06-18$4.24/sh−9,000$38,160→ 86,346 total - Award
Stock Option (Right to Buy)
2021-06-17+67,804→ 67,804 totalExercise: $4.29Exp: 2031-06-17→ Common Stock (67,804 underlying)
Footnotes (3)
- [F1]100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders.
- [F2]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F3]One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001580582
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:06 PM ET
- Size
- 9.1 KB